Research programme: protectans - Cleveland BioLabsAlternative Names: CBLB 613; Pifithrin-mu
Latest Information Update: 20 Jan 2012
At a glance
- Originator Cleveland BioLabs
- Class Proteins; Small molecules
- Mechanism of Action Stem cell stimulants; Tumour suppressor protein p53 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Chemoprotection; Radioprotection